Literature DB >> 2120205

The induction and suppression of prostaglandin H2 synthase (cyclooxygenase) in human monocytes.

J Y Fu1, J L Masferrer, K Seibert, A Raz, P Needleman.   

Abstract

We report here that the bacterial lipopolysaccharide endotoxin induces human blood monocytes in a time- and dose-dependent manner to release prodigious amounts of prostaglandins with thromboxane A2, the major metabolite formed. Cells responded to as little as 1 ng/ml lipopolysaccharide to release prostaglandin E2 and thromboxane A2 with maximal stimulation at 10 micrograms/ml. Lipopolysaccharide was found to induce increased activity of cyclooxygenase enzyme without affecting the activities of phospholipase and thromboxane synthase or the formation of 5-lipoxygenase products (e.g. leukotriene B4). The glucocorticoid dexamethasone completely blocked the lipopolysaccharide-induced prostanoid release by inhibiting the activity of monocyte cyclooxygenase. Dexamethasone did not affect phospholipase and thromboxane synthase activities or leukotriene formation. Immunoprecipitation of [35S]methionine-labeled cyclooxygenase confirmed that the effect of lipopolysaccharide and dexamethasone on the monocyte prostanoid production could be attributed to an increase or decrease, respectively, in cellular cyclooxygenase de novo synthesis.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2120205

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  133 in total

1.  COX-1 and COX-2 products in the gut: therapeutic impact of COX-2 inhibitors.

Authors:  B J Whittle
Journal:  Gut       Date:  2000-09       Impact factor: 23.059

Review 2.  Aspirin and other anti-inflammatory drugs.

Authors:  S J Vane
Journal:  Thorax       Date:  2000-10       Impact factor: 9.139

Review 3.  [Update of rheumatology--II. State and prospectives of chemotherapy in chronic arthritis].

Authors:  G Hein; T Eidner; P Oelzner; B Manger
Journal:  Med Klin (Munich)       Date:  1999-10-15

Review 4.  Cutaneous reactions to aspirin and nonsteroidal antiinflammatory drugs.

Authors:  Mario Sánchez-Borges; Arnaldo Capriles-Hulett; Fernan Caballero-Fonseca
Journal:  Clin Rev Allergy Immunol       Date:  2003-04       Impact factor: 8.667

5.  Raised levels of F(2)-isoprostanes and prostaglandin F(2alpha) in different rheumatic diseases.

Authors:  S Basu; M Whiteman; D L Mattey; B Halliwell
Journal:  Ann Rheum Dis       Date:  2001-06       Impact factor: 19.103

6.  Fish macrophages express a cyclo-oxygenase-2 homologue after activation.

Authors:  J Zou; N F Neumann; J W Holland; M Belosevic; C Cunningham; C J Secombes; A F Rowley
Journal:  Biochem J       Date:  1999-05-15       Impact factor: 3.857

Review 7.  Discovery of a new function of cyclooxygenase (COX)-2: COX-2 is a cardioprotective protein that alleviates ischemia/reperfusion injury and mediates the late phase of preconditioning.

Authors:  Roberto Bolli; Ken Shinmura; Xian-Liang Tang; Eitaro Kodani; Yu-Ting Xuan; Yiru Guo; Buddhadeb Dawn
Journal:  Cardiovasc Res       Date:  2002-08-15       Impact factor: 10.787

Review 8.  [New non-steroidal anti-rheumatic drugs: selective inhibitors of inducible cyclooxygenase].

Authors:  D O Stichtenoth; H Zeidler; J C Frölich
Journal:  Med Klin (Munich)       Date:  1998-07-15

9.  Nitric oxide activates cyclooxygenase enzymes.

Authors:  D Salvemini; T P Misko; J L Masferrer; K Seibert; M G Currie; P Needleman
Journal:  Proc Natl Acad Sci U S A       Date:  1993-08-01       Impact factor: 11.205

10.  Nitric oxide-mediated hyporeactivity to noradrenaline precedes the induction of nitric oxide synthase in endotoxin shock.

Authors:  C Szabó; J A Mitchell; C Thiemermann; J R Vane
Journal:  Br J Pharmacol       Date:  1993-03       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.